Clinical study design

Results: 811



#Item
321Performance in Initiating and Delivering (PID) Clinical Research UCLH Performance in Approving and Recruiting to Research October 2014 Since July 2012, providers of NHS services have been providing data on performance in

Performance in Initiating and Delivering (PID) Clinical Research UCLH Performance in Approving and Recruiting to Research October 2014 Since July 2012, providers of NHS services have been providing data on performance in

Add to Reading List

Source URL: www.uclh.nhs.uk

Language: English - Date: 2014-10-30 09:57:45
322VIRGINIA STATE UNIVERSITY INSTITUTIONAL REVIEW BOARD CONSENT TO PARTICIPATE IN RESEARH You are invited to participate in a research study of [Insert general statement about study]. We ask that you read this form and ask

VIRGINIA STATE UNIVERSITY INSTITUTIONAL REVIEW BOARD CONSENT TO PARTICIPATE IN RESEARH You are invited to participate in a research study of [Insert general statement about study]. We ask that you read this form and ask

Add to Reading List

Source URL: www.vsu.edu

Language: English - Date: 2012-09-04 13:11:48
323Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting September 2004 Protocol Number: Protocol Title:

Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting September 2004 Protocol Number: Protocol Title:

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-16 10:30:38
324HB 615: Cancer Clinical Trials Approved Study Plan Monica J. Lindeen, Commissioner of Securities and Insurance, Montana State Auditor September, 2011 A. INTRODUCTION With the passage of HB 615, the 2011 Legislature direc

HB 615: Cancer Clinical Trials Approved Study Plan Monica J. Lindeen, Commissioner of Securities and Insurance, Montana State Auditor September, 2011 A. INTRODUCTION With the passage of HB 615, the 2011 Legislature direc

Add to Reading List

Source URL: www.csi.mt.gov

Language: English - Date: 2011-10-21 16:02:28
325Ashland Final Report[removed]Appendix A

Ashland Final Report[removed]Appendix A

Add to Reading List

Source URL: www.mass.gov

Language: English - Date: 2013-08-30 23:04:06
326Synthesizing Information from Different Study Designs

Synthesizing Information from Different Study Designs

Add to Reading List

Source URL: www.fda.gov

Language: English
327I . . CLINICAL REVIEW FOR ENBREL (Etanercept) Jeffrey N. Siegel, M.D.

I . . CLINICAL REVIEW FOR ENBREL (Etanercept) Jeffrey N. Siegel, M.D.

Add to Reading List

Source URL: www.fda.gov

Language: English
328Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting September 2004 Protocol Number: Protocol Title:

Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting September 2004 Protocol Number: Protocol Title:

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-16 12:06:01
329I  To: Through:  STN[removed]

I To: Through: STN[removed]

Add to Reading List

Source URL: www.fda.gov

Language: English
330Microsoft Word - TS Clinical Trial Blurb for the Web.doc

Microsoft Word - TS Clinical Trial Blurb for the Web.doc

Add to Reading List

Source URL: tsa-usa.org

Language: English - Date: 2010-08-13 14:15:14